Puma Biotechnology (NASDAQ:PBYI) Research Coverage Started a

StockNews.com started coverage on shares of Puma Biotechnology (NASDAQ:PBYI – Free Report) in a report issued on Thursday. The brokerage issued a buy rating on the biopharmaceutical company’s stock. Several other equities research analysts also recently issued reports on PBYI. HC Wainwright reiterated a buy rating and set a $8.00 price objective on shares of […]

Related Keywords

United States , Troy Edward Wilson , Maximof Nougues , Commonwealth Equity Services , Securities Exchange Commission , Mackenzie Financial Corp , Balyasny Asset Management , Puma Biotechnology Company Profile , Puma Biotechnology Inc , Puma Biotechnology , Free Report , Exchange Commission , Director Troy Edward Wilson , Equity Services , Street Group , Financial Corp , Get Free Report , Puma Biotechnology Daily , Nasdaq Pbyi , Pbyi , Medical , Initiated Coverage , Stocknews Com ,